Kevin G. Cramton
CIK: 0001698197
Associated companies
Transaction History
| HP | ▲ Buy | Grant | 5,273 | $0 | 3/5/2026 | View on chart |
| HP | ▲ Buy | Grant | 7,177 | $0 | 3/6/2025 | View on chart |
| HP | ▲ Buy | Grant | 4,675 | $0 | 2/28/2024 | View on chart |
| HP | ▲ Buy | Grant | 4,197 | $0 | 3/1/2023 | View on chart |
| HP | ▲ Buy | Grant | 4,733 | $0 | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Susquehanna Raises Helmerich & Payne Price Target to $50
Susquehanna has maintained a positive outlook on Helmerich & Payne and raised its price target to $50. This move places the firm at the top of the current analyst consensus range, which averages $44.75. The stock is currently trading near its 200-day moving average, with the new target sitting above the recent 52-week high.
Susquehanna Raises Helmerich & Payne Price Target to $50. Susquehanna has maintained a positive outlook on Helmerich & Payne and raised its price target to $50. This move places the firm at the top of the current analyst consensus range, which averages $44.75. The stock is currently trading near its 200-day moving average, with the new target sitting above the recent 52-week high.